Open Access. Powered by Scholars. Published by Universities.®
- Discipline
Articles 1 - 10 of 10
Full-Text Articles in Life Sciences
T Cell Immunotherapy Of Infection Disease And Cancer, Scott Weber
T Cell Immunotherapy Of Infection Disease And Cancer, Scott Weber
Journal of Undergraduate Research
This project was focused on improving the immune response to infectious disease and cancer. We have engineered T cell receptors with 1000-fold increase in affinity and will characterize their value as diagnostics and therapeutics. In addition, we examined changes in T cell function due to the co-receptor CD5. We also examined how T cell responses to infection are dependent upon metabolic and epigenetic regulation.
Nf Κb As A Mediator In Iron Regulation, Erik D. Marchant, Chad Hancock
Nf Κb As A Mediator In Iron Regulation, Erik D. Marchant, Chad Hancock
Journal of Undergraduate Research
Doxorubicin (DOX) is a commonly used chemotherapy drug. Although it is very effective in treating many different types of cancer, it has also been shown to induce oxidative stress in multiple tissues, partially due to severe iron-dysregulation. The effects of DOX have mostly been studied in heart tissue, because DOX has been shown to increase the risk of cardiomyopathy and other heart diseases. Besides causing damage to the heart, DOX has also been shown to contribute to muscle wasting. For this purpose, we decided to investigate how DOX causes iron-dysregulation in C2C12 myotubes, which are immortalized cells from mouse skeletal …
Quantifying Predictive Value Of Biological Data Types In Machine Learning Models Of Cancer Outcome, Samantha Jensen, Stephen Piccolo
Quantifying Predictive Value Of Biological Data Types In Machine Learning Models Of Cancer Outcome, Samantha Jensen, Stephen Piccolo
Journal of Undergraduate Research
Precision medicine is a growing movement toward utilizing molecular diagnostics to guide medical decisions. It is particularly useful when applied to cancer treatment, as knowing details about cancer stage, genetic pathology, and tumor type can inform life-saving decisions. Increasingly, physicians may use genetic, proteomic, epigenetic, and expression data to determine treatment strategy and even choose specific chemotherapy drugs1.
Trf1 Mutations As A Mechanism For Telomere Length Maintenance In Cancer, Collin Sanderson, Jonathan Alder
Trf1 Mutations As A Mechanism For Telomere Length Maintenance In Cancer, Collin Sanderson, Jonathan Alder
Journal of Undergraduate Research
Telomeres are repetitive DNA sequences found on the ends of chromosomes that serve to protect the genes contained within each chromosome. As a cell replicates, its telomeres shorten, eventually triggering cellular senescence or death. This serves as a tumor suppressive mechanism by limiting the proliferation of cells. All cancers must overcome this growth limitation by acquiring mutations that permit telomere elongation. Most cancers achieve this by acquiring activating-mutations in an enzyme known as telomerase. Some cancers do not express telomerase, and maintain their telomeres by other means including a mechanism called “alternative lengthening of telomeres” (ALT). However, there exists a …
The Chemotherapeutic Potential Of Resveratrol-Based Treatments, Connor Peck, Kim O'Neill
The Chemotherapeutic Potential Of Resveratrol-Based Treatments, Connor Peck, Kim O'Neill
Journal of Undergraduate Research
Cancer is one of the most prevalent and deadly diseases in the world. In 2012 alone, there were approximately 14 million new cases of cancer and over 8 million cancer-related deaths worldwide. Despite extensive research in past decades, the burden of cancer continues to increase.
One of the most common treatments for cancer is chemotherapy, the use of various chemical substances that exhibit anti-cancer activity. Unfortunately, chemotherapy can be quite toxic and often produces inadequate results. There remains a great need for improved chemotherapeutic treatment strategies in order to improve outcomes for cancer patients.
The purpose of my project was …
Cellular Mechanism Of Thymidine Kinase 1 Secretion, Wei Meng, Kim O'Neill
Cellular Mechanism Of Thymidine Kinase 1 Secretion, Wei Meng, Kim O'Neill
Journal of Undergraduate Research
Cancer remains the second most common cause of death in the US, accounting for nearly 1 of every 4 deaths. Studies have shown that the early detection of cancer leads to better patient prognosis and a greater five-year survival rate. [1] Diagnostic and prognostic markers play a key role in classifying tumors and determining the best treatment plan for a patient. Among these biomarkers, Thymidine kinase 1 (TK1) has been studied extensively, primarily as a diagnostic biomarker for a variety of cancer types. TK1 plays a role in regulating the intracellular thymidine pools throughout the cell cycle, and thus regulates …
Transition From Cardiovascular Disease To Cancer As The Leading Cause Of Death In Us States, 1999-2014, Michael C. Harding, Evan Thacker
Transition From Cardiovascular Disease To Cancer As The Leading Cause Of Death In Us States, 1999-2014, Michael C. Harding, Evan Thacker
Journal of Undergraduate Research
In 1900 the three leading causes of death in the United States were pneumonia and influenza; tuberculosis; and gastritis, enteritis, and colitis.1 However, through a combination of improved sanitation, the discovery of antibiotics, and the advent of vaccination programs, deaths from infectious diseases subsided and soon gave way to chronic diseases.2 Shortly after the turn of the century, diseases of the heart became of the number one cause of death, and in the 1940s, cancer began consistently appearing at number two. Since then, heart disease and cancer have remained firmly entrenched as the number one and two causes …
Splice Site Predictor, Mark Wadsworth, Dr. Perry G. Ridge
Splice Site Predictor, Mark Wadsworth, Dr. Perry G. Ridge
Journal of Undergraduate Research
With the advent of nextgeneration sequencing, one of the unintended consequences is the sheer number of genomic variations requiring interpretation. Mutations in splice sites have been shown to contribute to the development of cancer [1], and dementia [2] among other potentially deadly disorders. Roughly 14 million people are diagnosed with cancer every year [3], and roughly 7 million with dementia [4]. Since these diseases cause an incredible amount of suffering, scientists in all fields are driven to search for ways to identify and treat them. These have been particularly difficult to interpret and have been largely ignored by the bioinformatics …
Targeting Superoxide Dismutase-¬1 In Cancer, Laura Oh, Josh Andersen
Targeting Superoxide Dismutase-¬1 In Cancer, Laura Oh, Josh Andersen
Journal of Undergraduate Research
SOD1 is overexpressed in many cancers such as lung adenocarcinoma, non- small-cell lung cancer, and 70% of primary breast cancers. Traditionally, SOD1 is known as an antioxidant in the human body, but only 1% of SOD1 expressed in cells is necessary to keep superoxide radicals below cytotoxic levels, suggesting that SOD1 may have undiscovered functions. One of the known trademarks of cancer is the Warburg Effect defined by up-regulated glycolysis and down- regulated respiration. It is thought that this unique mode of metabolism promotes cancer cell growth. A recent study demonstrated that SOD1 functions to repress respiration through the casein …
Role Of The Viral Lana Protein In Human Cancers Caused By Kaposi’S Sarcoma-Associated Herpesvirus, Gregory Low, Brad Berges
Role Of The Viral Lana Protein In Human Cancers Caused By Kaposi’S Sarcoma-Associated Herpesvirus, Gregory Low, Brad Berges
Journal of Undergraduate Research
The purpose of our experiment was to ascertain the importance of the LANA protein encoded by the Kaposi’s Sarcoma-Associated Herpesvirus (KSHV). LANA is believed to be essential for the survival of KSHV in human cells. KSHV causes a variety of cancers including Kaposi’s sarcoma (KS), multicentric Castleman’s disease (MCD), and primary effusion lymphoma (PEL). These cancers most often appear in the immunocompromised and can be fatal. The mortality rate of PEL is ~60% after one year, KS 5-year mortality rate is ~30%, and MCD 5-year mortality rate is 35%. No known vaccine or anti-viral drug treatment is currently licensed for …